Austin, Texas • Velocity Clinical Research
Phone: (512) 506-8287
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common form of chronic liver disease. Velocity is enrolling people with the following risk factors for MASH for a clinical trial: high blood pressure, high triglycerides, overweight, type 2 diabetes.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy